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Supporting Methods:
Synthesis of PFC@HSA nanoparticles
Generally, HSA (96 mg) and DTT were firstly mixed in 2.4 mL deionized water followed by stirring for 10 min. Then, 200 μL alcohol was added followed by shaking for another 3 min. PFTBA (0.6 mL), Perfluoroocytlbromide (PFOB) (0.6 mL), Perfluorotripropylamine (PFTPA) (0.48 mL) and Perfluorodecalin (FDC) (0.12 mL) or Perfluoro-N-methylcyclohexylpiperidineand (FMCP) (0.48 mL) and FDC (0.12 mL) were added gradually to the solution in an ice bath under at 300 W sonication for 6 min to form stable PFC@HSA nanoparticles.
Effects of PFC@HSAs on platelets function

Platelet preparation
Blood of Balb /C male mice was collected into tubes containing sodium citrate as anticoagulant. Then, blood was centrifuged at 203 g for 8 min, and PRP (platelet-rich plasma) was collected into a fresh tube. PRP was further centrifuged at 1028 g for 5 min after addition of PGI2 (125 ng/mL). Platelets (4×10 8 cells/mL) were finally re-suspended in modified Tyrodes-Hepes buffer (134 mM NaCl, 2.9 mM KCl, 0.34 mM Na2HPO4.12H2O, 12 mM NaHCO3, 20 mM Hepes and 1 mM MgCl2, pH 7.3).
Clot retraction
PRP was prepared as previously described. 200 μL mouse PRP was firstly mixed with 50 μL Vehicle (32mg/mL HSA) or 50 μL PFC@HSAs. Then, the solution was raised to 1mL with modified TyrodesHepes buffer, and then 5 μL of red blood cells were added. Fibrin clot formation was initiated by adding 5 μL thrombin (200 U/mL). Clot retraction around a glass capillary added before clot formation was observed over a period of 90 min at room temperature. Blood clot weight and extruded serum weight were measured as markers of blood clot retraction. was added to each well, followed by incubating for additional 1 h. Finally, the absorbance was measured at 450 nm using a microplate reader. 
Effects of PFTBA@HSA on tumor cell and normal cells
NIR
Tumor vessel permeation assay
For Evans Blue permeation assay, mice were intravenously injected with 10 mL/kg different PFTBA@HSA or Vehicle. 5 h later, Evans Blue (40 mg/kg) was injected intravenously. The mice were sacrificed and tumors were collected after another 3 h. One part of the tumors was embedded in OCT (Sakura, Japan) and cut into 8 μm slices. The immunofluorescence images of the slices were observed by confocal microscope (Nikon, Japan).
For Dextran (2000 kDa) permeation assay, mice were firstly intravenously injected with 10 mL/kg PFTBA@HSA or Vehicle. 5 h later, Dextran (40 mg/kg) was injected intravenously. The mice were sacrificed and tumors were collected after another 3 h. One part of the tumors was embedded in OCT (Sakura, Japan) and cut into 8 μm slices. The immunofluorescence images of the slices were observed 5 by confocal microscope (Nikon, Japan).
Effects of PFTBA@HSA on RBCs infiltration
RBCs infiltration in tumor was detected by hemoglobin detection, tumors were firstly excised from the sacrificed animals. Then, the tumors were weighed and homogenized in Drabkin's reagent (Sigma) followed by centrifuging at 15000 g for 10 min. The hemoglobin content of supernatants was measured by absorbance at 540 nm.
Effects of PFTBA@HSA on in situ tumor metastasis
Generally, Balb/C mice bearing subcutaneous 4T1 tumors (~100 mm 3 ) were randomly divided into four groups (n=5): (a) Vehicle (32 mg/mL HSA, 10 mL/kg); (b) PFTBA@HSA (10 mL/kg); These drugs were given at day 0, day 3 and day 7. At day 14, the in situ tumors were removed and the wound sites were sewn with thread. Finally, the lung metastases were calculated after another 24 days.
Effects of PFTBA@HSA on TGF-β Activation
To detect the TGF-β in serum, mice were divided into three groups (n=5): (a) Vehicle (32 mg/mL HSA, 10 mL/kg); (b) PFTBA@HSA (10 mL/kg); (c) Ticagrelor (10 mg/kg). 10 h later, the mice were sacrificed and the blood were collected. Then, the latent and active TGF-β were detected by Elisa Kit (Dakewe, China).
Statistical Analysis
Data are presented as mean ± SD. Statistical analysis was performed via one-way ANOVA.
Meanwhile, post hoc analysis was performed using the Wilcoxon rank sum test with a Bonferroni correction if needed. *p<0.05 was considered statistically significant, and **p<0.01 and ***p<0.001
were extremely significant.
6 Figure S1 . Zeta Potential curve of PFTBA@HSA. 
